Acute transcutaneous auricular vagus nerve stimulation is associated with lower baroreflex sensitivity without detectable Mayer-wave coherence change: an exploratory study
Abstract
Transcutaneous auricular vagus nerve stimulation (taVNS) delivers afferent inputs, but cardiovascular responses are heterogeneous and autonomic outcomes are not interchangeable. In this exploratory, non-randomised, open-label study, 18 healthy men completed fixed-order five-minute Pre, left-cymba Stim, and Post phases without sham. Spontaneous sequence baroreflex sensitivity (BRS seq, all ; designated centrally post hoc) was lower during Stim than Pre (8.54 ± 5.57 versus 6.49 ± 3.89 ms/mmHg; paired mean difference − 2.05, BCa 95% CI − 3.81 to − 1.10; Wilcoxon p = 2.29 × 10 − 5 ; Cohen’s d z = − 0.74), with negative differences in 17/18 participants. Mayer-band coherence and representative heart rate variability indices showed no detectable Stim–Pre differences. Systolic blood pressure was higher during Stim. Recovery of BRS was not established. No adverse events were reported after the sessions. Sequence BRS estimates blood pressure–R–R interval gain, whereas heart rate variability and coherence quantify different properties. This pattern supports prospective evaluation of sequence BRS as a session-level physiological response measure. The design does not establish stimulation-specific engagement, direct vagal inhibition, clinical utility, or a monitoring threshold. Sham-controlled replication is required.
Trial registration: Japan Registry of Clinical Trials (jRCT), jRCT1032230440. Registered on 9 November 2023.
Related
- Reduced total arterial compliance in frail older adults is associated with orthostatic blood pressure variability but not baroreflex sensitivity.
- Analysis of taVNS effects on baroreflex sensitivity and autonomic nervous system regulation during head-up tilt test
- Distinguishing clinical efficacy from vagal target engagement in perioperative transcutaneous auricular vagus nerve stimulation.
- Transcutaneous auricular vagus nerve stimulation demonstrates effects on pupil responses in Parkinson's disease
- Heart rate and blood pressure variability, and baroreflex sensitivity, during heat exposure in persons with type 2 diabetes and hypertension
BibTeX
@article{katahara2026acute,
title = {{Acute transcutaneous auricular vagus nerve stimulation is associated with lower baroreflex sensitivity without detectable Mayer-wave coherence change: an exploratory study}},
author = {Yusuke Katahara and Atsuhiko Iijima and Kazuki Tainaka},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-71625-9},
url = {https://www.nature.com/articles/s41598-026-71625-9},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Acute transcutaneous auricular vagus nerve stimulation is associated with lower baroreflex sensitivity without detectable Mayer-wave coherence change: an exploratory study
AU - Yusuke Katahara
AU - Atsuhiko Iijima
AU - Kazuki Tainaka
PY - 2026
DA - 2026/10/14
JO - Scientific Reports
DO - 10.1038/s41598-026-71625-9
UR - https://www.nature.com/articles/s41598-026-71625-9
AB - Transcutaneous auricular vagus nerve stimulation (taVNS) delivers afferent inputs, but cardiovascular responses are heterogeneous and autonomic outcomes are not interchangeable. In this exploratory, non-randomised, open-label study, 18 healthy men completed fixed-order five-minute Pre, left-cymba Stim, and Post phases without sham. Spontaneous sequence baroreflex sensitivity (BRS seq, all ; designated centrally post hoc) was lower during Stim than Pre (8.54 ± 5.57 versus 6.49 ± 3.89 ms/mmHg; paired mean difference − 2.05, BCa 95% CI − 3.81 to − 1.10; Wilcoxon p = 2.29 × 10 − 5 ; Cohen’s d z = − 0.74), with negative differences in 17/18 participants. Mayer-band coherence and representative heart rate variability indices showed no detectable Stim–Pre differences. Systolic blood pressure was higher during Stim. Recovery of BRS was not established. No adverse events were reported after the sessions. Sequence BRS estimates blood pressure–R–R interval gain, whereas heart rate variability and coherence quantify different properties. This pattern supports prospective evaluation of sequence BRS as a session-level physiological response measure. The design does not establish stimulation-specific engagement, direct vagal inhibition, clinical utility, or a monitoring threshold. Sham-controlled replication is required. Trial registration: Japan Registry of Clinical Trials (jRCT), jRCT1032230440. Registered on 9 November 2023.
SN - 2045-2322
ER -